Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ACG Clinical Guideline: Alcohol-Associated Liver Disease
Loretta Jophlin, Ashwani K. Singal, Ramón Bataller, et al.
The American Journal of Gastroenterology (2023) Vol. 119, Iss. 1, pp. 30-54
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

Management of alcohol use disorder: a gastroenterology and hepatology-focused perspective
Luis Antonio Díaz, Daniel König, Sabine Weber, et al.
˜The œLancet. Gastroenterology & hepatology (2025)
Closed Access | Times Cited: 2
Changing landscape of alcohol‐associated liver disease in younger individuals, women, and ethnic minorities
Juan Pablo Arab, Winston Dunn, Gene Y. Im, et al.
Liver International (2024) Vol. 44, Iss. 7, pp. 1537-1547
Open Access | Times Cited: 9
Hepatoprotective potential of four fruit extracts rich in different structural flavonoids against alcohol-induced liver injury via gut microbiota-liver axis
Yunyi Chen, Hanbing Ma, Jiaojiao Liang, et al.
Food Chemistry (2024) Vol. 460, pp. 140460-140460
Closed Access | Times Cited: 9
Evolution of Liver Transplantation Indications: Expanding Horizons
Sara Battistella, Marco Grasso, Elisa Catanzaro, et al.
Medicina (2024) Vol. 60, Iss. 3, pp. 412-412
Open Access | Times Cited: 7
Alcohol-associated liver disease increases the risk of muscle loss and mortality in patients with cirrhosis
Tatsunori Hanai, Kayoko Nishimura, Shinji Unome, et al.
Journal of Gastroenterology (2024) Vol. 59, Iss. 10, pp. 932-940
Open Access | Times Cited: 5
Liver fibrosis screening increases alcohol abstinence
Emma Avitabile, Jordi Gratacós‐Ginès, Martina Pérez, et al.
JHEP Reports (2024) Vol. 6, Iss. 10, pp. 101165-101165
Open Access | Times Cited: 4
Non-invasive testing in metabolic dysfunction-associated steatotic liver disease
Sanad Dawod, Kimberly Brown
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 4
1-Minute Pearls/Pitfalls for the Clinician
Kwame Dapaah-Afriyie
Journal of Brown Hospital Medicine (2025) Vol. 4, Iss. 1
Closed Access
Transitioning from NAFLD to MAFLD and MASLD: the toxic relationship with alcohol consumption
Mübin Özercan, Ahmed Tawheed, Mohamed El‐Kassas
Exploration of Medicine (2025)
Open Access
In acute alcoholic hepatitis, does the combination of a corticosteroid and pentoxifylline result in better outcomes than either agent alone?
Hailon Wong, Manuella Constantino, Catherine Scudlo, et al.
Evidence-Based Practice (2025)
Closed Access
Cyclic nucleotide phosphodiesterases as drug targets
Michy P. Kelly, Viacheslav O. Nikolaev, Leila Gobejishvili, et al.
Pharmacological Reviews (2025) Vol. 77, Iss. 3, pp. 100042-100042
Open Access
Naltrexone for Alcohol Use Disorder in Cirrhosis: Bridging the Gap in an Understudied Population
Romina Vergara-Quispe, David Martí‐Aguado, Ramón Bataller
Journal of Clinical and Experimental Hepatology (2025) Vol. 15, Iss. 2, pp. 102509-102509
Closed Access
Liver Transplantation in Alcohol-Associated Liver Disease
Elias D. Rady, Ahmad Anouti, Chanattha Thimphitthaya, et al.
Clinics in Liver Disease (2025)
Closed Access
Evidence construction of Silibinin capsules against alcoholic liver disease based on a meta-analysis and systematic review
Yan Wang, Wenmin Yang, Yuan Yang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
The impact of integrated care on clinical outcomes in patients with alcohol-associated liver disease: Early outcomes from a multidisciplinary clinic
Shreya Sengupta, Akhil Anand, Qijun Yang, et al.
Hepatology Communications (2025) Vol. 9, Iss. 2
Open Access
Young Adults and Alcohol-Associated Liver Cancer: Incidence and Death from 2000 to 2021
Pojsakorn Danpanichkul, Yanfang Pang, Luis Antonio Díaz, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 609-609
Open Access
A Comprehensive Review of Metabolic Dysfunction-Associated Steatotic Liver Disease: Its Mechanistic Development Focusing on Methylglyoxal and Counterbalancing Treatment Strategies
Izabela Berdowska, M. Matusiewicz, Izabela Fecka
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2394-2394
Open Access
Reduced survival for rural patients with hepatocellular carcinoma within a tertiary hospital network: treatment equality is not enough
Andrew R. Chin, Ali Galalah Mostafa Ismail, Weijun Fan, et al.
Internal Medicine Journal (2025)
Closed Access
Hepatoprotective Effects of Citri reticulatae Pericarpium and Chaenomelese speciosa (Sweet) Nakai Extracts in Alcohol-Related Liver Injury: Modulation of Oxidative Stress, Lipid Metabolism, and Gut Microbiota
Shuangshuang Ma, Lingtao Kang, Zhipeng Gao, et al.
Antioxidants (2025) Vol. 14, Iss. 3, pp. 343-343
Open Access
Differential candidate characteristics associated with increasing ALD and MASH among liver transplant listings in the US
Ashwani K. Singal, Winston Dunn, Robert J. Wong, et al.
Digestive and Liver Disease (2025)
Closed Access
Emergency admission, previous delirium tremens and increased liver stiffness as risk factors for severe alcohol withdrawal – A prospective study
Tobias Zellner, Jacques-Thierry Metzger, Elias Bekka, et al.
PLoS ONE (2025) Vol. 20, Iss. 3, pp. e0320083-e0320083
Open Access
Monitoring and treatment of alcohol use disorder: An integrated multidisciplinary model
Ashwani K. Singal
Metabolism and Target Organ Damage (2025) Vol. 5, Iss. 1
Open Access
Best Practices, Resources and Innovations: A Mechanistic Review of Nausea and Vomiting Management Options in Cirrhosis
Claudio Tombazzi, Sara Martin
Current Hepatology Reports (2025) Vol. 24, Iss. 1
Open Access
Alcohol-Metabolizing Enzymes, Liver Diseases and Cancer
Tao Liu, Feiyu Zhang, Yue Feng, et al.
Seminars in Liver Disease (2025)
Open Access
New Biomarkers in Liver Fibrosis: A Pass through the Quicksand?
Marzia Tagliaferro, Mariapaola Marino, Valerio Basile, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 8, pp. 798-798
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top